IBRX vs CYTK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

IBRX

38.7
AI Score
VS
CYTK Wins

CYTK

61.1
AI Score

Investment Advisor Scores

IBRX

39score
Recommendation
AVOID NEW MONEY

CYTK

61score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IBRX CYTK Winner
Forward P/E 123.4568 117.6471 CYTK
PEG Ratio 0 -0.42 Tie
Revenue Growth 93.9% -57.1% IBRX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 38.7/100 61.1/100 CYTK
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CYTK

Relative Price Performance (Last 90 Days)

IBRX 1M: -3.7% · 3M: +17.0% CYTK 1M: -5.3% · 3M: -22.8%

Current Technical Phase

IBRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.5 · Price: $8.31

CYTK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.3%), weak momentum, RSI 39

RSI (14): 39.3 · Price: $62.33

Fundamentals Snapshot

Metric IBRX CYTK
Market Cap — —
Forward P/E -113.4 -14.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.9% -0.6%
Gross Margin 1.0% -5.0%
Operating Margin -1.2% -6.3%
EPS -0.97 -7.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CYTK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.